Levin A. Arthur's Insider Trades & SAST Disclosures
Levin A. Arthur's most recent trade in Stoke Therapeutics Inc was a trade of 4,842 Restricted Stock Units done . Disclosure was reported to the exchange on March 19, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Levin A. Arthur.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Stoke Therapeutics Inc | Arthur A. Levin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2025 | 4,842 | 4,842 | - | - | Restricted Stock Units | |
| Apple Inc | Arthur D. Levinson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 1,113 | 1,113 | - | - | Restricted Stock Unit | |
| Apple Inc | Arthur D. Levinson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 1,516 | 0 | - | - | Restricted Stock Unit | |
| Apple Inc | Arthur D. Levinson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 1,516 | 4,161,092 (0%) | 0% | - | Common Stock | |
| Apple Inc | Arthur D. Levinson | Director | Sale of securities on an exchange or to another person at price $ 226.35 per share. | 01 Feb 2025 | 1,516 | 4,159,576 (0%) | 0% | 226.4 | 343,147 | Common Stock |
| Avidity Biosciences Inc | Arthur A. Levin | Director | Sale of securities on an exchange or to another person at price $ 28.60 per share. | 21 Jan 2025 | 1,872 | 12,958 | - | 28.6 | 53,537 | Common Stock |
| Avidity Biosciences Inc | Arthur A. Levin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2024 | 3,323 | 0 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Arthur A. Levin | Director | Sale of securities on an exchange or to another person at price $ 42.12 per share. | 19 Nov 2024 | 3,323 | 14,830 | - | 42.1 | 139,973 | Common Stock |
| Avidity Biosciences Inc | Arthur A. Levin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.24 per share. | 19 Nov 2024 | 3,323 | 18,153 | - | 1.2 | 4,121 | Common Stock |
| Apple Inc | Arthur D. Levinson | Director | Sale of securities on an exchange or to another person at price $ 228.66 per share. | 15 Nov 2024 | 75,000 | 4,209,576 (0%) | 0% | 228.7 | 17,149,500 | Common Stock |
| Apple Inc | Arthur D. Levinson | Director | Sale of securities on an exchange or to another person at price $ 224.68 per share. | 15 Nov 2024 | 75,000 | 4,284,576 (0%) | 0% | 224.7 | 16,851,000 | Common Stock |
| Apple Inc | Arthur D. Levinson | Director | Sale of securities on an exchange or to another person at price $ 229.28 per share. | 15 Nov 2024 | 50,000 | 4,159,576 (0%) | 0% | 229.3 | 11,464,000 | Common Stock |
| Avidity Biosciences Inc | Arthur A. Levin | Director | Sale of securities on an exchange or to another person at price $ 46.63 per share. | 21 Oct 2024 | 5,000 | 14,830 | - | 46.6 | 233,168 | Common Stock |
| Avidity Biosciences Inc | Arthur A. Levin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Oct 2024 | 5,000 | 3,323 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Arthur A. Levin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.24 per share. | 21 Oct 2024 | 5,000 | 19,830 | - | 1.2 | 6,200 | Common Stock |
| Avidity Biosciences Inc | Arthur A. Levin | Director | Sale of securities on an exchange or to another person at price $ 45.73 per share. | 19 Sep 2024 | 5,000 | 14,830 | - | 45.7 | 228,658 | Common Stock |
| Avidity Biosciences Inc | Arthur A. Levin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.24 per share. | 19 Sep 2024 | 5,000 | 19,830 | - | 1.2 | 6,200 | Common Stock |
| Avidity Biosciences Inc | Arthur A. Levin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Sep 2024 | 5,000 | 8,323 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Arthur A. Levin | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Sep 2024 | 22,500 | 131,372 | - | 0 | Common Stock | |
| Avidity Biosciences Inc | Arthur A. Levin | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Sep 2024 | 22,500 | 22,500 | - | 0 | Common Stock | |
| Avidity Biosciences Inc | Arthur A. Levin | Director | Sale of securities on an exchange or to another person at price $ 45.19 per share. | 19 Aug 2024 | 5,000 | 14,830 | - | 45.2 | 225,947 | Common Stock |
| Avidity Biosciences Inc | Arthur A. Levin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Aug 2024 | 5,000 | 13,323 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Arthur A. Levin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.24 per share. | 19 Aug 2024 | 5,000 | 19,830 | - | 1.2 | 6,200 | Common Stock |
| Avidity Biosciences Inc | Arthur A. Levin | Director | Sale of securities on an exchange or to another person at price $ 45.01 per share. | 19 Jul 2024 | 5,000 | 14,830 | - | 45.0 | 225,069 | Common Stock |
| Avidity Biosciences Inc | Arthur A. Levin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jul 2024 | 5,000 | 18,323 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Arthur A. Levin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.24 per share. | 19 Jul 2024 | 5,000 | 19,830 | - | 1.2 | 6,200 | Common Stock |
| Avidity Biosciences Inc | Arthur A. Levin | Director | Sale of securities on an exchange or to another person at price $ 37.59 per share. | 20 Jun 2024 | 5,000 | 14,830 | - | 37.6 | 187,951 | Common Stock |
| Avidity Biosciences Inc | Arthur A. Levin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jun 2024 | 5,000 | 23,323 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Arthur A. Levin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.24 per share. | 20 Jun 2024 | 5,000 | 19,830 | - | 1.2 | 6,200 | Common Stock |
| Avidity Biosciences Inc | Arthur A. Levin | Director | Sale of securities on an exchange or to another person at price $ 40.08 per share. | 12 Jun 2024 | 60,000 | 153,872 | - | 40.1 | 2,404,782 | Common Stock |
| Avidity Biosciences Inc | Arthur A. Levin | Director | Sale of securities on an exchange or to another person at price $ 35.07 per share. | 12 Jun 2024 | 40,000 | 213,872 | - | 35.1 | 1,402,628 | Common Stock |
| Avidity Biosciences Inc | Arthur A. Levin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 13,489 | 13,489 | - | - | Stock Option (Right to Buy) | |
| Stoke Therapeutics Inc | Arthur A. Levin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 7,639 | 7,639 | - | - | Director Stock Option (Right to Buy) | |
| Apple Inc | Arthur D. Levinson | Director | Sale of securities on an exchange or to another person at price $ 191.58 per share. | 30 May 2024 | 75,000 | 4,359,576 (0%) | 0% | 191.6 | 14,368,500 | Common Stock |
| Avidity Biosciences Inc | Arthur A. Levin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2024 | 5,000 | 28,323 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Arthur A. Levin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.24 per share. | 20 May 2024 | 5,000 | 19,830 | - | 1.2 | 6,200 | Common Stock |
| Avidity Biosciences Inc | Arthur A. Levin | Director | Sale of securities on an exchange or to another person at price $ 29.90 per share. | 20 May 2024 | 5,000 | 14,830 | - | 29.9 | 149,481 | Common Stock |
| Avidity Biosciences Inc | Arthur A. Levin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Apr 2024 | 5,000 | 33,323 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Arthur A. Levin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.24 per share. | 19 Apr 2024 | 5,000 | 19,830 | - | 1.2 | 6,200 | Common Stock |
| Avidity Biosciences Inc | Arthur A. Levin | Director | Sale of securities on an exchange or to another person at price $ 22.82 per share. | 19 Apr 2024 | 5,000 | 14,830 | - | 22.8 | 114,123 | Common Stock |
| Avidity Biosciences Inc | Arthur A. Levin | Director | Sale of securities on an exchange or to another person at price $ 27.11 per share. | 03 Apr 2024 | 20,000 | 253,872 | - | 27.1 | 542,214 | Common Stock |
| Avidity Biosciences Inc | Arthur A. Levin | Director | Sale of securities on an exchange or to another person at price $ 23.97 per share. | 19 Mar 2024 | 5,000 | 14,830 | - | 24.0 | 119,848 | Common Stock |
| Avidity Biosciences Inc | Arthur A. Levin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Mar 2024 | 5,000 | 38,323 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Arthur A. Levin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.24 per share. | 19 Mar 2024 | 5,000 | 19,830 | - | 1.2 | 6,200 | Common Stock |
| Avidity Biosciences Inc | Arthur A. Levin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2024 | 25,000 | 43,323 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Arthur A. Levin | Director | Sale of securities on an exchange or to another person at price $ 22.04 per share. | 12 Mar 2024 | 25,000 | 17,471 | - | 22.0 | 550,915 | Common Stock |
| Avidity Biosciences Inc | Arthur A. Levin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.24 per share. | 12 Mar 2024 | 25,000 | 42,471 | - | 1.2 | 31,000 | Common Stock |
| Avidity Biosciences Inc | Arthur A. Levin | Director | Sale of securities on an exchange or to another person at price $ 22.00 per share. | 12 Mar 2024 | 2,641 | 14,830 | - | 22 | 58,102 | Common Stock |
| Apple Inc | Arthur D. Levinson | Director | Sale of securities on an exchange or to another person at price $ 180.94 per share. | 28 Feb 2024 | 100,000 | 4,434,576 (0%) | 0% | 180.9 | 18,094,000 | Common Stock |
| Apple Inc | Arthur D. Levinson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 1,516 | 1,516 | - | - | Restricted Stock Unit | |
| Apple Inc | Levinson Arthur D. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 1,852 | 4,534,576 (0%) | 0% | - | Common Stock | |
| Apple Inc | D. Arthur Levinson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 1,852 | 0 | - | - | Restricted Stock Unit | |
| Avidity Biosciences Inc | Levin A. Arthur | Director | Sale of securities on an exchange or to another person at price $ 10.13 per share. | 22 Jan 2024 | 1,859 | 17,471 | - | 10.1 | 18,832 | Common Stock |
| Stoke Therapeutics Inc | Arthur A. Levin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 19,441 | 19,441 | - | - | Director Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Arthur A. Levin | Director | Sale of securities on an exchange or to another person at price $ 22.01 per share. | 15 Mar 2023 | 100 | 19,330 | - | 22.0 | 2,201 | Common Stock |
| Avidity Biosciences Inc | Arthur A. Levin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2023 | 100 | 68,323 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Arthur A. Levin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.24 per share. | 15 Mar 2023 | 100 | 19,430 | - | 1.2 | 124 | Common Stock |
| Apple Inc | Arthur D. Levinson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2023 | 1,852 | 1,852 | - | - | Restricted Stock Unit | |
| Avidity Biosciences Inc | Arthur A. Levin | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.24 per share. | 14 Feb 2023 | 10,000 | 29,330 | - | 1.2 | 12,400 | Common Stock |
| Avidity Biosciences Inc | Arthur A. Levin | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2023 | 10,000 | 68,423 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Arthur A. Levin | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 23.62 per share. | 14 Feb 2023 | 9,477 | 19,853 | - | 23.6 | 223,890 | Common Stock |
| Avidity Biosciences Inc | Arthur A. Levin | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 24.24 per share. | 14 Feb 2023 | 523 | 19,330 | - | 24.2 | 12,677 | Common Stock |
| Apple Inc | Arthur D. Levinson | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Feb 2023 | 1,685 | 4,532,724 (0%) | 0% | 0 | Common Stock | |
| Apple Inc | Arthur D. Levinson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2023 | 1,685 | 0 | - | - | Restricted Stock Unit | |
| Apple Inc | Arthur D. Levinson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2023 | 1,685 | 4,534,409 (0%) | 0% | - | Common Stock | |
| Avidity Biosciences Inc | Arthur A. Levin | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 144,000 | 144,000 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Arthur A. Levin | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 18,000 | 19,330 | - | 0 | Common Stock | |
| Avidity Biosciences Inc | Arthur A. Levin | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 22.00 per share. | 12 Jan 2023 | 10,000 | 1,330 | - | 22.0 | 220,028 | Common Stock |
| Avidity Biosciences Inc | Arthur A. Levin | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2023 | 10,000 | 78,423 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Arthur A. Levin | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.24 per share. | 12 Jan 2023 | 10,000 | 11,330 | - | 1.2 | 12,400 | Common Stock |
| Avidity Biosciences Inc | Arthur A. Levin | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Dec 2022 | 40,000 | 88,423 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Arthur A. Levin | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 22.01 per share. | 29 Dec 2022 | 40,000 | 1,330 | - | 22.0 | 880,568 | Common Stock |
| Avidity Biosciences Inc | Arthur A. Levin | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.24 per share. | 29 Dec 2022 | 40,000 | 41,330 | - | 1.2 | 49,600 | Common Stock |
| Avidity Biosciences Inc | Arthur A. Levin | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 22.12 per share. | 12 Aug 2022 | 62,498 | 1,330 | - | 22.1 | 1,382,343 | Common Stock |
| Avidity Biosciences Inc | Arthur A. Levin | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.24 per share. | 12 Aug 2022 | 34,758 | 63,828 | - | 1.2 | 43,100 | Common Stock |
| Avidity Biosciences Inc | Arthur A. Levin | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2022 | 34,758 | 131,922 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Arthur A. Levin | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2022 | 27,740 | 0 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Arthur A. Levin | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.53 per share. | 12 Aug 2022 | 27,740 | 29,070 | - | 0.5 | 14,702 | Common Stock |
| Avidity Biosciences Inc | Arthur A. Levin | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2022 | 14,003 | 27,740 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Arthur A. Levin | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.53 per share. | 12 Aug 2022 | 14,003 | 15,333 | - | 0.5 | 7,422 | Common Stock |
| Avidity Biosciences Inc | Arthur A. Levin | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 22.00 per share. | 12 Aug 2022 | 14,003 | 1,330 | - | 22 | 308,066 | Common Stock |
| Avidity Biosciences Inc | Arthur A. Levin | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2022 | 3,499 | 128,423 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Arthur A. Levin | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.24 per share. | 12 Aug 2022 | 3,499 | 4,829 | - | 1.2 | 4,339 | Common Stock |
| Avidity Biosciences Inc | Arthur A. Levin | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 22.08 per share. | 12 Aug 2022 | 3,499 | 1,330 | - | 22.1 | 77,257 | Common Stock |
| Stoke Therapeutics Inc | Arthur A. Levin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 21,000 | 21,000 | - | - | Director Stock Option (Right to Buy) | |
| Apple Inc | Arthur D. Levinson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 1,685 | 1,685 | - | - | Restricted Stock Unit | |
| Apple Inc | Arthur D. Levinson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2022 | 1,986 | 0 | - | - | Restricted Stock Unit | |
| Apple Inc | Arthur D. Levinson | Director | Sale of securities on an exchange or to another person at price $ 173.29 per share. | 01 Feb 2022 | 1,986 | 4,532,724 (0%) | 0% | 173.3 | 344,154 | Common Stock |
| Apple Inc | Arthur D. Levinson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2022 | 1,986 | 4,534,710 (0%) | 0% | - | Common Stock | |
| Avidity Biosciences Inc | Arthur A. Levin | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2022 | 115,500 | 115,500 | - | - | Stock Option (Right to Buy) | |
| NextNRG Inc. | Arthur Levine | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2022 | 125,951 | 125,951 | - | - | Stock Option | |
| NextNRG Inc. | Arthur Levine | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2022 | 22,321 | 48,894 | - | - | Common Stock | |
| Avidity Biosciences Inc | Arthur A. Levin | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 27.89 per share. | 18 Nov 2021 | 25,000 | 1,330 | - | 27.9 | 697,218 | Common Stock |
| Avidity Biosciences Inc | Arthur A. Levin | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.24 per share. | 18 Nov 2021 | 24,396 | 25,726 | - | 1.2 | 30,251 | Common Stock |
| Avidity Biosciences Inc | Arthur A. Levin | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2021 | 24,396 | 166,770 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Arthur A. Levin | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.53 per share. | 18 Nov 2021 | 604 | 26,330 | - | 0.5 | 320 | Common Stock |
| Avidity Biosciences Inc | Arthur A. Levin | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2021 | 604 | 41,743 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Arthur A. Levin | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 27.97 per share. | 24 Jun 2021 | 17,453 | 3,977 | - | 28.0 | 488,166 | Common Stock |
| Avidity Biosciences Inc | Arthur A. Levin | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.24 per share. | 24 Jun 2021 | 17,017 | 18,347 | - | 1.2 | 21,101 | Common Stock |
| Avidity Biosciences Inc | Arthur A. Levin | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2021 | 17,017 | 191,166 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Arthur A. Levin | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.53 per share. | 24 Jun 2021 | 3,083 | 21,430 | - | 0.5 | 1,634 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges